Enhanced adhesion of monocytes via reverse signaling triggered by decoy receptor 3

Experimental Cell Research

Volumn 292, Issue 2, 2004, Pages 241-251

  Hsu, Ming Jen ^a   Lin, Wan Wan ^a   Tsao, Wei Chia ^a   Chang, Yung Chi ^b   Hsu, Tsui Ling ^b   Chiu, Allen W ^c   Chio, Chung Ching ^c   Hsieh, Shie Liang ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

DcR3; Monocyte adhesion; Reverse signaling; Signal transduction; THP 1

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIN; BUTANOL; DECOY RECEPTOR 3; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FOCAL ADHESION KINASE; HERBIMYCIN A; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; STAUROSPORINE; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; BONE MARROW CELL; CELL ADHESION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; MOLECULE; MONOCYTE; PRIORITY JOURNAL;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0346362275     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2003.09.019     Document Type: Article

References (48)

1. Yu K.Y., Kwon B., Ni J., Zhai Y., Ebner R., Kwon B.S. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 274:1999;13733-13736.
2. Simonet W.S., Lacey D.L., Dunstan C.R., Kelly M., Chang M.S., Luthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 89:1997;309-319.
3. Pitti R.M., Marsters S.A., Lawrence D.A. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 396:1998;699-703.
4. Roth W., Isenmann S., Nakamura M., Platten M., Wick W., Kleihues P., Bahr M., Ohgaki H., Ashkenazi A., Weller M. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res. 61:2001;2759-2765.
5. Bai C., Connolly B., Metzker M.L., Hilliard C.A., Liu X., Sandig V., Soderman A., Galloway S.M., Liu Q., Austin C.P., Caskey C.T. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc. Natl. Acad. Sci. U. S. A. 97:2000;1230-1235.
6. Otsuki T., Tomokuni A., Sakaguchi H., Aikoh T., Matsuki T., Isozaki Y., Hyodoh F., Ueki H., Kusaka M., Kita S., Ueki A. Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients. Clin. Exp. Immunol. 119:2000;323-327.
7. Ohshima K., Haraoka S., Sugihara M., Suzumiya J., Kawasaki C., Kanda M., Kikuchi M., Sheikh M.S., Fornace A.J. Jr. Amplification and expression of a decoy receptor for Fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas death and decoy receptors and p53-mediated apoptosis. Cancer Lett. 160:2000;89-97.
8. Connolly K., Cho Y.H., Duan R., Fikes J., Gregorio T., Lafleur D.W., Okoye Z., Salcedo T.W., Santiago G., Ullrich S. In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptor. J. Pharmacol. Exp. Ther. 298:2001;25-33.
9. Zhang J., Salcedo T.W., Wan X., Ullrich S., Hu B., Gregorio T., Feng P., Qi S., Chen H., Cho Y.H. Modulation of T-cell responses to alloantigens by TR6/DcR3. J. Clin. Invest. 107:2001;1459-1468.
10. Migone T.S., Zhang J., Luo X., Zhuang L., Chen C., Hu B., Hong J.S., Perry J.W., Chen S.F., Zhou J.X., Cho Y.H., Ullrich S., Kanakaraj P., Carrell J., Boyd E., Olsen H.S., Hu G., Pukac L., Liu D., Ni J., Kim S., Gentz R., Feng P., Moore P.A., Ruben S., Wei P. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity. 16:2002;479-492.
11. Hsu T.L., Chang Y.C., Chen S.J., Liu Y.J., Chiu A.W., Chio C.C., Chen L., Hsieh S.L. Modulation of dendritic cell differentiation and maturation by decoy receptor 3. J. Immunol. 168:2002;4846-4853.
12. Suzuki I., Fink P.J. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187:1998;123-128.
13. Wan X., Zhang J., Luo H., Shi G., Kapnik E., Kim S., Kanakaraj P., Wu J. A TNF family member LIGHT transduces costimulatory signals into human T cells. J. Immunol. 169:2002;6813-6821.
14. Shi G., Luo H., Wan X., Salcedo T.W., Zhang J., Wu J. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood. 100:2002;3279-3286.
15. Chen N.J., Huang M.W., Hsieh S.L. Enhanced secretion of IFN-γ by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J. Immunol. 166:2001;270-276.
16. Zhai Y., Guo R., Hsu T.L., Yu G.L., Ni J., Kwon B.S., Jiang G.W., Lu J., Tan J., Ugustus M.et al. LIGHT, a novel ligand for lymphotoxin β receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J. Clin. Invest. 102:1998;1142-1151.
17. Lipfert L., Haimovich B., Schaller M.D., Cobb B.S., Parsons J.T., Brugge J.S. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J. Cell Biol. 119:1992;905-912.
18. Schaller M.D., Borgman C.A., Cobb B.S., Vines R.R., Reynolds A.B., Parsons J.T. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. U. S. A. 89:1992;5192-5196.
19. Roach T., Slater S., Koval M., White L., Cahir McFarl E.D., Okumura M., Thomas M., Brown E. CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr. Biol. 7:1997;408-417.
20. Hauck C.R., Hsia D.A., Schlaepfer D.D. Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J. Biol. Chem. 275:2000;41092-41099.
21. Jones R.J., Brunton V.G., Frame M.C. Adhesion-linked kinases in cancer; emphasis on src, focal adhesion kinase and PI 3-kinase. Eur. J. Cancer. 36:2000;1595-1606.
22. Abu-Ghazaleh R., Kabir J., Jia H., Lobo M., Zachary I. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem. J. 360:2001;255-264.
23. Kumar P., Hosaka S., Koch A.E. Soluble E-selectin induces monocyte chemotaxis through src family tyrosine kinases. J. Biol. Chem. 276:2001;21039-21045.
24. Shen T.L., Guan J.L. Differential regulation of cell migration and cell cycle progression by FAK complexes with src, PI3K, Grb7 and Grb2 in focal contacts. FEBS Lett. 499:2001;176-181.
25. Bolen J.B., Rowley R.B., Spana C., Tsygankov A.Y. Src family of tyrosine protein kinases in hemopoietic signal transduction. FASEB J. 6:1992;3403-3409.
26. Tada J., Omine M., Suda T., Yamaguchi N. A common signaling pathway via Syk and Lyn tyrosine kinases generated from capping of the sialomucins CD34 and CD43 in immature hematopoietic cells. Blood. 93:1999;3723-3735.
27. Ridley A., Hall A. Signal transduction pathways regulating Rho-mediated stress fiber formation. EMBO J. 13:1994;2600-2610.
28. Tatosyan A.G., Mizenina O.A. Kinases of the Src family: structure and functions. Biochemistry. 65:2000;49-58.
29. Schlaepfer D.D., Hanter T. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases. Mol. Cell. Biol. 16:1996;5623-5633.
30. Li L., Okura M., Imamoto A. Focal adhesions require catalytic activity of Src family kinases to mediate integrin-matrix adhesion. Mol. Cell. Biol. 22:2002;1203-1217.
31. Chen H.C., Appeddu P.A., Isoda H., Guan J.L. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J. Biol. Chem. 271:1996;26329-26334.
32. Zvara A., Fajardo J.E., Escalante M., Cotton G., Muir T., Kirsch K.H., Birge R.B. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II. Oncogene. 20:2001;951-961.
33. Akagi T., Murata K., Shishido T., Hanafusa H. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras. Mol. Cell. Biol. 22:2002;7015-7023.
34. Frame M.C., Fincham V.J., Carragher N.O., Wyke J.A. v-Src's hold over actin and cell adhesions. Nat. Rev. Mol. Cell Biol. 3:2002;233-245.
35. Felsenfeld D.P., Schwartzberg P.L., Venegas A., Tse R., Sheetz M.P. Selective regulation of integrin-cytoskeleton interactions by the tyrosine kinase Src. Nat. Cell Biol. 1:1999;200-206.
36. Chan V.W., Meng F., Soriano P., DeFranco A.L., Lowell C.A. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity. 7:1997;69-81.
37. Cornall R.J., Cyster J.G., Hibbs M.L., Dunn A.R., Otipoby K.L., Clark E.A., Goodnow C.C. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity. 8:1998;497-508.
38. Tu L.C., Chou C.K., Chen H.C., Yeh S.F. Protein kinase C-mediated tyrosine phosphorylation of paxillin and focal adhesion kinase requires cytoskeletal integrity and is uncoupled to mitogen-activated protein kinase activation in human hepatoma cells. J. Biomed. Sci. 8:2001;184-190.
39. Petricoin E. III, David M., Igarashi K., Benjamin C., Ling L., Golez S., Finbloom D.S., Laner A.C. Inhibition of alpha interferon but not gamma interferon signal transduction by phorbol esters is mediated by a tyrosine phosphatase. Mol. Cell. Biol. 16:1996;1419-1424.
40. Zachary I., Sinnett-Smith J., Turner C.E., Rozengurt E. Bombesin, vasopressin, and endothelin rapidly stimulate tyrosine phosphorylation of the focal adhesion-associated protein paxillin in Swiss 3T3 cells. J. Biol. Chem. 268:1993;22060-22065.
41. Etienne S., Adamson P., Greenwood J., Strosberg A.D., Cazaubon S., Gould P.O., Woodgett J.R., Cooper J.A., Buss J.E., Shalloway D., Hunter T. Protein kinase C phosphorylates pp60src at a novel site. Cell. 42:1985;849-857.
42. Schlaepfer D.D., Jones K.C., Hunter T. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events. Mol. Cell. Biol. 18:1998;2571-2585.
43. Schlaepfer D.D., Hunter T.T. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src. J. Biol. Chem. 272:1997;13189-13195.
44. Schlaepfer D.D., Broome M.A., Hunter T. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins. Mol. Cell. Biol. 17:1997;1702-1713.
45. Zhao H., Li Y., Fucini R.V., Ross S.E., Pessin J.E., Koretzky G.A. T cell receptor-induced phosphorylation of Sos requires activity of CD45, Lck, and protein kinase C, but not ERK. J. Biol. Chem. 272:1997;21625-21634.
46. Miranti C.K., Ohno S., Brugge J.S. Protein kinase C regulates integrin-induced activation of the extracellular regulated kinase pathway upstream of Shc. J. Biol. Chem. 274:1999;10571-10581.
47. Etienne-Manneville S., Manneville J.B., Adamson P., Wilbourn B., Greenwood J., Couraud P.O. ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J. Immunol. 165:2000;3375-3383.
48. Cui X., Hawari F., Alsaaty S., Lawrence M., Combs C.A., Geng W., Rouhani F.N., Miskinis D., Levine S.J. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J. Clin. Invest. 110:2002;515-526.